These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26283553)

  • 1. Cholera in pregnancy: Clinical and immunological aspects.
    Khan AI; Chowdhury F; Leung DT; Larocque RC; Harris JB; Ryan ET; Calderwood SB; Qadri F
    Int J Infect Dis; 2015 Oct; 39():20-4. PubMed ID: 26283553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh.
    Chowdhury F; Khan AI; Harris JB; LaRocque RC; Chowdhury MI; Ryan ET; Faruque AS; Calderwood SB; Qadri F
    Pediatr Infect Dis J; 2008 Nov; 27(11):986-92. PubMed ID: 18833030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.
    Qadri F; Ryan ET; Faruque AS; Ahmed F; Khan AI; Islam MM; Akramuzzaman SM; Sack DA; Calderwood SB
    Infect Immun; 2003 Aug; 71(8):4808-14. PubMed ID: 12874365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh.
    Harris AM; Bhuiyan MS; Chowdhury F; Khan AI; Hossain A; Kendall EA; Rahman A; LaRocque RC; Wrammert J; Ryan ET; Qadri F; Calderwood SB; Harris JB
    Infect Immun; 2009 Sep; 77(9):3850-6. PubMed ID: 19528207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh.
    Harris JB; Podolsky MJ; Bhuiyan TR; Chowdhury F; Khan AI; Larocque RC; Logvinenko T; Kendall J; Faruque AS; Nagler CR; Ryan ET; Qadri F; Calderwood SB
    PLoS Negl Trop Dis; 2009; 3(3):e403. PubMed ID: 19333369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh.
    Aktar A; Rahman MA; Afrin S; Faruk MO; Uddin T; Akter A; Sami MIN; Yasmin T; Chowdhury F; Khan AI; Leung DT; LaRocque RC; Charles RC; Bhuiyan TR; Mandlik A; Kelly M; Kováč P; Xu P; Calderwood SB; Harris JB; Qadri F; Ryan ET
    Clin Vaccine Immunol; 2016 May; 23(5):427-435. PubMed ID: 27009211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139.
    Asaduzzaman M; Ryan ET; John M; Hang L; Khan AI; Faruque AS; Taylor RK; Calderwood SB; Qadri F
    Infect Immun; 2004 Aug; 72(8):4448-54. PubMed ID: 15271902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of egg yolk immunoglobulins (IgYs) developed against recombinant immunogens CtxB, OmpW and TcpA on infant mice infected with Vibrio cholerae.
    Taheri F; Nazarian S; Ahmadi TS; Gargari SLM
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107054. PubMed ID: 33065385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure.
    Taylor RK; Kirn TJ; Meeks MD; Wade TK; Wade WF
    Infect Immun; 2004 Oct; 72(10):6050-60. PubMed ID: 15385509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local production of anti-vibrio cholerae mucosal antibody in reproductive tract tissues after cholera.
    Ryan ET; Bridges EA; Crean TI; Gausia K; Hamadani JD; Aziz A; Hawkes S; Begum M; Bogaerts J; Faruque SM; Salam MA; Fuchs GJ; Calderwood SB
    J Infect Dis; 2001 Sep; 184(5):643-7. PubMed ID: 11494170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh.
    Chowdhury F; Akter A; Bhuiyan TR; Biswas R; Firoj MG; Tauheed I; Harris JB; Larocque RC; Ross AG; McMillan NAJ; Charles RC; Ryan ET; Calderwood SB; Qadri F
    Front Immunol; 2022; 13():1067737. PubMed ID: 36618409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
    Fernandez-Miyakawa ME; Brero ML; Mateo NA
    Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.
    Glass RI; Svennerholm AM; Khan MR; Huda S; Huq MI; Holmgren J
    J Infect Dis; 1985 Feb; 151(2):236-42. PubMed ID: 3968450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.
    Mayo-Smith LM; Simon JK; Chen WH; Haney D; Lock M; Lyon CE; Calderwood SB; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Harris JB
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27847368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.
    Clemens J; Rao M; Sack D; Ahmed F; Khan MR; Chakraborty J; Kay B; Huda S; Yunus M; van Loon F
    Am J Epidemiol; 1995 Oct; 142(7):759-64. PubMed ID: 7572947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.
    Qadri F; Ahmed F; Karim MM; Wenneras C; Begum YA; Abdus Salam M; Albert MJ; McGhee JR
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):812-8. PubMed ID: 10548569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice.
    Rollenhagen JE; Kalsy A; Cerda F; John M; Harris JB; Larocque RC; Qadri F; Calderwood SB; Taylor RK; Ryan ET
    Infect Immun; 2006 Oct; 74(10):5834-9. PubMed ID: 16988262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.
    Gupta RK; Szu SC; Finkelstein RA; Robbins JB
    Infect Immun; 1992 Aug; 60(8):3201-8. PubMed ID: 1639490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.